GDF-15 and suPAR biomarkers provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Do GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention?
Patients undergoing transcatheter tricuspid valve intervention
GDF-15 and suPAR biomarkers
Short-term risk stratification
GDF-15 and suPAR offer incremental prognostic value for short-term risk stratification following transcatheter tricuspid valve intervention.
Absolute Event Rate: 0% vs 0%
GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Building similarity graph...
Analyzing shared references across papers
Loading...
Christoph Edlinger
University of Salzburg
Johannes Schlegl
Medizinische Hochschule Brandenburg Theodor Fontane
Marwin Bannehr
Structural Heart Disease
Biomarkers in Medicine
Otto-von-Guericke University Magdeburg
University of Salzburg
Paracelsus Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...
Edlinger et al. (Mon,) reported a other. GDF-15 and suPAR biomarkers provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
synapsesocial.com/papers/6996a887ecb39a600b3ef5fc — DOI: https://doi.org/10.1080/17520363.2026.2628970